NCT07211854View on ClinicalTrials.gov

Antithrombotic Strategies in Coronary Artery Dilatations and Aneurysms

CompletedOBSERVATIONAL
Enrollment

51

Participants

Timeline

Start Date

September 6, 2024

Primary Completion Date

September 11, 2024

Study Completion Date

September 11, 2024

Conditions
Coronary Artery Dilatations and Aneursyms
Interventions
OTHER

Anticoagulant Treatment

Follow-up of patients with coronary aneurysms and treatments introduced (anticoagulants and/or antiplatelet agents) to monitor the onset of ischaemic or haemorrhagic complications between 2013 and 2023.

Trial Locations (1)

78150

Centre Hospitalier de Versailles, Le Chesnay

All Listed Sponsors
lead

Franck Assayag

OTHER

NCT07211854 - Antithrombotic Strategies in Coronary Artery Dilatations and Aneurysms | Biotech Hunter | Biotech Hunter